Production (Stage)
DarioHealth Corp.
DRIO
$0.7196
$0.00160.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -11.20% | 2.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.20% | 2.44% | |||
| Cost of Revenue | -5.63% | -4.00% | |||
| Gross Profit | -13.35% | 5.15% | |||
| SG&A Expenses | -6.87% | -5.75% | |||
| Depreciation & Amortization | -32.07% | -4.17% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.85% | -4.68% | |||
| Operating Income | 13.99% | 9.07% | |||
| Income Before Tax | 2.87% | 23.22% | |||
| Income Tax Expenses | -85.81% | 1,292.31% | |||
| Earnings from Continuing Operations | 4.20% | 21.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.20% | 21.88% | |||
| EBIT | 13.99% | 9.07% | |||
| EBITDA | 2.73% | 18.81% | |||
| EPS Basic | -15.55% | 49.41% | |||
| Normalized Basic EPS | -75.32% | 63.70% | |||
| EPS Diluted | -15.55% | 50.36% | |||
| Normalized Diluted EPS | -75.32% | 63.70% | |||
| Average Basic Shares Outstanding | -39.94% | 95.16% | |||
| Average Diluted Shares Outstanding | -39.94% | 95.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||